New shot aims to tame eye inflammation in uveitis patients
NCT ID NCT07547995
First seen May 02, 2026 · Last updated May 21, 2026 · Updated 3 times
Summary
This study tests a new drug called GenSci048 for people with active non-infectious uveitis, a condition causing eye inflammation. About 111 adults will receive either the drug or a placebo as a shot under the skin. The main goal is to see if the drug reduces treatment failure over 25 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye & Ent Hospital of Fudan University
Shanghai, Shanghai Municipality, 200031, China
Conditions
Explore the condition pages connected to this study.